News

26.08.2019

"We make no compromises in creating the highest potential company"

Versant Ventures has a strong history in building successful companies such as Therachon, Black Diamond or CRISPR  Therapeutics. We talked to Alex Mayweg, partner at Versant Ventures in Basel, about the beauty of Versant Ventures discovery engine Ridgeline Therapeutics, translating science into successful drug development programs and the future of drug discovery.

mehr >
23.09.2019

Daten, Roboter, Scratch: Das war der Digitaltag 2019

Daten, Roboter, Scratch: Das war der Digitaltag 2019

Die Digitalisierung gilt als eines der bestimmenden Themen für Wirtschaft und Gesellschaft. Was der Sammelbegriff umfasst und wie sich die Digitalisierung auf das Leben und Arbeiten auswirkt, zeigte der Digitaltag, der am 3. September 2019 schweizweit zum dritten Mal stattfand. In Basel konnten sich die Besucherinnen und Besucher auf dem Meret Oppenheim-Platz über die Fortschritte und Möglichkeiten der Digitalisierung informieren.

mehr >
20.09.2019

Roche receives FDA approval for first whole blood test

Roche receives FDA approval for first whole blood test

The U.S. Food and Drug Administration (FDA) has given Roche the green light for its cobas Babesia test, the first commercial whole blood test for donor screening. The test is meant to reduce the risk of transmitting the Babesia parasite through blood transfusions.

mehr >
08.07.2019

"Patient centricity means communicating on eye level"

The university hospital of Basel not only wants to use innovation, but also drive innovation. For this reason, the hospital established an Innovation Lab recently and launched an internal support program to help put innovation projects into practice. Driving forces behind this initiative are Jens Eckstein and Marc Strasser. DayOne asked Jens Eckstein about this push for innovation.

mehr >
19.09.2019

What we learned at this year’s DayOne Conference

Twenty-two panellists and speakers, among them 3 patients and digital health futurist Maneesh Juneja, 30 project champions and their mentors, 40 volunteers and 450 participants and Arcondis as conference Partner  — this was the DayOne Conference which took place on September 9 at the FHNW in Muttenz.

mehr >
18.09.2019

Sécurité et transformation numérique pour les PME

Jeudi soir, 05. Septembre 2019, une petite centaine de personnes participaient à l’évènement « Sécurité et transformation numérique » pour les PME au Cinemont à Delémont. Une thématique hautement d’actualité en cette période où le nombre de cas de cyber attaques se multiplient et touche également des PME.

mehr >
11.06.2019

"I am amazed by the level of innovation in the Jura"

The Switzerland Innovation Park Basel Area already has two sites, in Allschwil and Basel, and will soon add a third in the Jura. It will be located on the Innodel campus in the municipality of Courroux, between Delémont and Courrendlin. Work is ongoing at the Jura site, which is set to officially open on 25 October.

mehr >
17.09.2019

Indigo Agriculture opens European headquarters in Basel

Indigo Agriculture opens European headquarters in Basel

Indigo Agriculture is expanding to Europe and has opened headquarters in Basel to this end. The U.S. company offers pioneering technologies for the agricultural sector. BaselArea.swiss supported Indigo in relocating to Basel.

mehr >
12.09.2019

Basel is among the world’s best universities

Basel is among the world’s best universities

The University of Basel is among the world’s top 100 universities, according to the Times Higher Education University Ranking. In 4th place in Switzerland, the university is kicking off the autumn semester with more new students than last year.

mehr >
06.05.2019

“Here at Bell, we combine handcraft and automation”

“Here at Bell, we combine handcraft and automation”

Over the space of 150 years, a butcher’s in Basel has grown into an international food company, with the Bell Food Group now employing more than 12,000 people in 15 countries. Markus Ettlin, Head of Industry 4.0/Automation at the Bell Food Group, provides an update on the company’s current Industry 4.0 projects, the limits of automation, and innovations in the food sector.

mehr >
10.09.2019

La transformation industrielle commence au Switzerland Innovation Park Basel Area

La transformation industrielle commence au Switzerland Innovation Park Basel Area

C’est un programme plein d’activités qui vous attend au Switzerland Innovation Park Basel Area, site du Jura, sur le Campus technologique innodel à Courroux depuis cette rentrée.

mehr >
09.09.2019

Fresh capital for biopharmaceutical companies

Fresh capital for biopharmaceutical companies

The two Basel-based biopharmaceutical companies Strekin and Novaremed have secured fresh capital. This will allow them to drive forward development of their drug candidates. Novaremed is developing a drug to combat Diabetic Neuropathic Pain, while Strekin’s development activities are focused on treating Sudden Sensorineural Hearing Loss.

mehr >
02.04.2019

“The Basel region is very advanced in healthcare innovation”

“The Basel region is very advanced in healthcare innovation”

A new master’s degree at the FHNW University of Applied Sciences and Arts Northwestern Switzerland aims to prepare the next generation of professionals in the life sciences industries: Students in “Medical Informatics” are trained to apply the latest technologies during projects for the medical and pharmaceutical industries. Professor Enkelejda Miho from the Institute for Medical and Analytical Technologies at FHNW is confident that the combination of life sciences, informatics and business brings forward a desired new profile of professionals.

mehr >
06.09.2019

Basel startup aims to change agriculture sector

Basel startup aims to change agriculture sector

Growcer AG is currently building a machine-operated vegetable farm in Basel. Robots sow, water and fertilize the vegetables, which are then harvested by humans. The concept promises to drastically reduce carbon emissions, water and fertilizer.

mehr >
05.09.2019

Leading startups benefit from BaselArea.swiss

Leading startups benefit from BaselArea.swiss

The top 100 startups of Switzerland have been revealed. In Venturelab’s Top 100, the Basel region performs particularly well in the biotech sector, while almost all the Basel companies named have benefited directly or indirectly from BaselArea.swiss.

mehr >
28.03.2019

33 recently arrived companies create hundreds of jobs

Basel and the Rhine - attractive for companies (img: Basel Tourismus)

The efforts of BaselArea.swiss proved extremely successful in 2018. 33 companies – seven more than in the previous year – were persuaded to move to the Basel economic region. 16 companies arrived from Europe, nine of which came from Germany. BaselArea.swiss also supported six Swiss companies in the search for a suitable business location in the Basel region. Of the newly arrived companies, 19 operate in the life sciences and chemicals sectors.

mehr >
04.09.2019

Basel promotes itself as digital hub

Basel promotes itself as digital hub

The Basel region also took the Swiss Digital Day as occasion to highlight its strengths in the area of digitalization. In the life sciences hub, digitalization plays a special role in personalized medicine, as the Vice President of the University of Basel explained in an interview.

mehr >
03.09.2019

Basel is artificial intelligence hub

Basel is artificial intelligence hub

The canton of Basel-Stadt is one of the three largest Swiss technology clusters for advanced digitalization technologies, as the new Digitalization Atlas has revealed. It is especially strong in artificial intelligence, with Roche, in particular, filing many patents in this area.  

mehr >
05.03.2019

Healthcare innovations gain traction with the DayOne Accelerator

Healthcare innovations gain traction with the DayOne Accelerator

Three innovative healthcare startups participate in the first round of the DayOne Accelerator. Faraz Oloumi from Aurteen, Chang Yun from Noul and Christian Vogler and Leo Gschwind from Advancience are examples of how far conviction can get you.

mehr >
30.08.2019

Basel researchers uncover the key to stem cell reproduction

Basel researchers uncover the key to stem cell reproduction

Scientists at the University of Basel have discovered why stem cells no longer proliferate as we get older. In so doing, they have also discovered how this sleep mode can be reversed, opening up the possibility of new forms of treatment in the process.

mehr >
27.08.2019

BaseLaunch supports Switzerland as an innovation location

BaseLaunch supports Switzerland as an innovation location

Switzerland often receives awards for its innovative strength. Life sciences have generally played a huge part in this acclaim. The BaseLaunch accelerator operated by BaselArea.swiss is a major reason for innovation, a media report has found.

mehr >
05.02.2019

“We are a small company with a big portfolio”

“We are a small company with a big portfolio”

After Martine and Jean-Paul Clozel created Actelion with two other founders and grew Actelion into Europe’s biggest biotech, the company and its late-stage pipeline were acquired by Johnson&Johnson in 2017. With Actelion’s discovery- and early-stage R&D assets, the couple formed Idorsia, with the vision to build one of Europe’s leading biopharmaceutical companies

mehr >
22.08.2019

Basel could be next tourism hotspot

Basel could be next tourism hotspot

Readers of “the Guardian” may be tempted to spend the next European heatwave in Basel. In an inviting article about Rhine swimming, the British newspaper delves into Basel’s quality of life.

mehr >
20.08.2019

Vaxxilon receives grant for vaccine development

Vaxxilon receives grant for vaccine development

Vaxxilon develops synthetic vaccines in order to combat resistant bacteria. Having received funding from the CARB-X network, a Phase 1 clinical trial can now also be conducted. BaselArea.swiss is a member of CARB-X.

mehr >
08.01.2019

"It doesn't always have to stay the same"

Désirée Mettraux has been the CEO of Creadi since 2016. The Pax spin-off has developed the Simpego online insurance platform. The insurance expert is confident that the industry will profit if it opens itself up to partners. The aim is to make insurance fun.

mehr >
19.08.2019

Endress+Hauser develops research facilities

Endress+Hauser develops research facilities

Endress+Hauser, the manufacturers of measuring devices based in Reinach BL, has developed two hygiene and wastewater testing facilities. These are to be integrated into operations at the School of Life Sciences in Muttenz BL.

mehr >
16.08.2019

Basel-based researcher combating multi-resistant bacteria

Basel-based researcher combating multi-resistant bacteria

Nina Khanna Gremmelmaier has been awarded this year’s prize for science of the City of Basel. The University Hospital Basel doctor was honored for her work into combating resistance to antibiotics.

mehr >
03.12.2018

“Momentum for blockchain in healthcare is growing in Basel”

“Momentum for blockchain in healthcare is growing in Basel”

Marco Cuomo and Daniel Fritz from Novartis got engaged in blockchain two years ago. Today, their aim is set high: With other pharma companies under the Innovative Medicines Initiative, they formed a “Blockchain Enabled Healthcare” program, due to kick off in 2019. The program that they presented at the Blockchain Leadership Summit in Basel – Switzerland’s largest conference in this field - wants no less than to define how blockchain is applied in healthcare.

mehr >
15.08.2019

Basel researchers revolutionizing the CRISPR-Cas method

Basel researchers revolutionizing the CRISPR-Cas method

The CRISPR-Cas method allows genes contained within a cell to be modified. As a general rule, the method could previously only be used to modify a single gene. Basel-based researchers have now successfully refined the method, allowing them to apply it to 25 – or more – genes at the same time.

mehr >
12.08.2019

Adobe develops new technology in Basel

Adobe develops new technology in Basel

The US-based company Adobe is developing a technology in Basel that will make it possible to display content on screens more quickly. Basel is a central R&D location for the American software provider, says Christoph Kull, head of Central Europe at Adobe.

mehr >
23.11.2018

Expats like Basel best

Expats like Basel best

Expats find Basel to be the best city in Switzerland, according to a study published by InterNations. Six Swiss cities were analyzed as part of its latest Expat City Ranking.

mehr >
08.08.2019

DayOne gains importance

DayOne gains importance

DayOne, a BaselArea.swiss initiative, is creating a world-leading healthcare innovation hub based on the strengths of the Basel region. A further important partner has joined to help achieve this goal.

mehr >
05.08.2019

Basel-based pharma groups successfully combating cancer

Basel-based pharma groups successfully combating cancer

Two Basel-based pharma groups, Roche and Novartis, have reported development progress for drugs aimed at combating cancer indications. Both companies announced positive findings from their respective Phase III trials.

mehr >
14.11.2018

Roivant raised USD 200 million, now valued at USD 7 billion

Roivant raised USD 200 million, now valued at USD 7 billion

The Basel-based pharmaceutical company Roivant Sciences has raised USD 200 million in a funding round. As a result, the company is now valued at an estimated USD 7 billion.

mehr >
30.07.2019

Clinerion supporting German university

Clinerion supporting German university

Clinerion, the Basel health data specialist, is giving students at Dresden International University access to its platform. Students will consequently learn to deal with de-identified Real World Data.

mehr >
29.07.2019

Synendos Therapeutics awarded EU funding

Synendos Therapeutics awarded EU funding

Synendos Therapeutics AG with headquarters in Allschwil is benefiting from the financial support for which small and medium-sized enterprises can apply within the framework of Horizon 2020, a program launched by the EU. The pharma company is also supported by the start-up accelerator BaseLaunch.

mehr >
05.11.2018

Three entrepreneurs, three visions of Industry 4.0

Dominik Trost (holo|one), Philippe Kapfer (NextDay.Vision), Roy Chikballapur (MachIQ)

BaselArea.swiss invited startups and Industry 4.0 projects to participate in the first Industry 4.0 Challenge. A jury from the industry chose three finalists: Philippe Kapfer with NextDay.Vision, Roy Chikballapur with MachIQ and Dominik Trost with holo|one. Learn more about their contributions and visions in the interview. You can meet the entrepreneurs at the Salon Industries du Futur Mulhouse on 20 and 21 November 2018.

mehr >
26.07.2019

Basel researchers shed light on muscle regeneration

Researchers at the University of Basel have made important discoveries regarding muscle regeneration. These findings may eventually facilitate treatment of age-related muscle weakness.

mehr >
25.07.2019

Roche benefits from new medicines

Roche benefits from new medicines

Basel pharma company Roche is very pleased with its financial results for the first half of 2019 and raises its outlook for the year as a whole. This positive performance was driven by high demand for new medicines.

mehr >
27.09.2018

"I Was Always One of Few Women in the Industry"

SOLO Swiss in Porrentruy in the canton of Jura has been making industrial furnaces for heat-treating metals since 1924. The family company with a global presence is developing against the backdrop of Industry 4.0 and is struggling to find the qualified workforce which is indispensable for what it does amid the effects of the strong franc and what are sometimes restrictive administrative regulations. Interview with Anne-Sophie Spérison, President and CEO.

mehr >

 

(Source: http://www.baselarea.swiss/en/baselarea-swiss/channels/innovation-report.html)